Interferon Beta-1a/Albumin

Brand name: Rebif

Rank #223 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$60.7M

Total Cost

Share:

5,917

Total Claims

$60.7M

Total Cost

373

Prescribers

$10K

Cost per Claim

0

Beneficiaries

6,028

30-Day Fills

$163K

Avg Cost/Provider

16

Avg Claims/Provider

Share of Medicare Part D Spending

0.02%

of total Medicare Part D spending

$60.7M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $60.7M total

🔎 Data Overview

💰

At $10,254 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.

🔍

Average cost of $162,660 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Interferon Beta-1a/Albumin

#ProviderSpecialtyLocationClaimsCost
1Jesus LoveraNeurologyNew Orleans, LA62$655K
2Randall TrudellNeurologyKnoxville, TN51$526K
3Mirela CerghetNeurologyDetroit, MI52$515K
4Arthur ItkinNeurologyPalos Heights, IL40$475K
5Vanessa Licona SanjuanNeurologyAlbuquerque, NM39$404K
6Katelyn MccormackNurse PractitionerAmherst, NY38$391K
7Christopher SheppardNeurologyUniontown, OH36$382K
8Gurubasappa MotgiNeurologyDesoto, TX35$374K
9Ute TraugottNeurologyArmonk, NY36$369K
10Katelyn MccormackNurse PractitionerAmherst, NY35$352K
11Jane AchenbachNeurologyCambridge, MN35$352K
12Gary HurstNurse PractitionerPost Falls, ID35$351K
13Anton SvetlanovNeurologyEdison, NJ28$342K
14Bethany MerrittNurse PractitionerHurricane, WV32$338K
15James BowenNeurologyKirkland, WA31$337K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
220Buprenorphine (Buprenorphine)$61.1M156,598
221Ferric Citrate (Auryxia)$60.7M32,798
222Dextromethorphan Hbr/Quinidine (Nuedexta)$60.7M60,863
223Interferon Beta-1a/Albumin (Rebif)$60.7M5,917
224Sodium Zirconium Cyclosilicate (Lokelma)$60.2M77,902
225Golimumab (Simponi Aria)$59.9M8,718
226Olanzapine (Olanzapine)$59.4M1,444,781

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology